-
2022-501644-15-00
4
Mild Cognitive Impairment due to Alzheimer's Disease Alzheimer's Disea
-
2024-515362-13-00
10
Philadelphia-negative myeloproliferative neoplasms are frequent and ch
-
2024-519994-20-00
5
Agitation Associated with Alzheimer’s Disease
-
2025-522556-10-01
4
Ocular Sequelae in Lyell syndrome
-
2025-524289-56-00
6
Asthma
-
2025-521711-39-00
5
2026-05-17
Lewy body Dementia psychosis (LBDP)
-
2024-518006-40-00
5
2025-11-13
Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia Due to AD)
-
2023-505486-92-00
4
2024-02-09
Small bowel adenocarcinoma
-
2022-503148-41-00
4
2023-12-01
Alzheimer's disease
-
2023-505046-26-00
5
2026-05-07
Colon carcinoma
-
2024-516966-12-00
4
2026-02-13
Alzheimer’s disease
-
2025-521710-25-00
4
2025-12-04
Lewy Body Dementia Psychosis (LBDP)
-
2025-520612-34-00
5
2025-11-28
Agitation Associated with
Alzheimer’s Disease
-
2024-519048-33-00
10
2025-11-25
resected pancreatic adenocarcinoma
-
2024-518008-33-00
5
2025-11-12
Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia due to AD)
-
2024-515162-13-00
5
2025-04-29
Eosinophilic Asthma
-
2023-507351-29-00
5
2024-12-03
Alzheimer's Disease Psychosis
-
2024-515300-39-00
4
2024-10-18
METASTATIC GRADE 3 POORLY DIFFERENTIATED NEUROENDOCRINE CARCINOMA OF G
-
2024-515297-27-00
5
2024-08-14
colon carcinoma
-
2023-507407-59-00
5
2024-07-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2023-505214-23-00
5
2024-06-07
colon carcinoma
-
2023-506885-30-00
5
2024-03-26
Adult patients with intermediate low or mid rectal adenocarcinoma to b
-
2024-514952-34-00
5
2023-06-23
Catheter related bloodstream infections due to Staphylococcus aureus
-
2023-506891-28-00
5
2022-05-02
The target population of interest in this study is participants with l